For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Potential First-in-Class Respiratory Combination Vaccine Candidates SCB-1022 (RSV + hMPV) and SCB-1033 (RSV + hMPV + PIV3) Enter the Clinical Trial Stage -- ...

In JAMA, the peer-reviewed medical journal, the ousted board members fired off against Kennedy’s cull. They wrote that the dismissals and the resulting replacement with MAHA minions, as well as the ...

The 17 members of a federal vaccine advisory committee, who were ousted last week, argued their abrupt dismissal has "left the U.S. vaccine program critically weakened." The group, speaking ...

Merck’s MRK second-largest product is Gardasil, which is a vaccine for the prevention of certain cancers caused by human ...

The Federal Reserve meets today with potential impacts on your finances, plus a warning for anyone reusing passwords.

Note that some links may require registration or subscription. A physician who supplied Matthew Perry with ketamine prior to ...

Tourists in Israel and Lebanon have found themselves stranded at airports amid Israel's conflict with Iran. Fiona Jones ...